Development of scalable, versatile, and cost-effective processes for iPSC-derived cell therapy manufacturing via linear scale-up (up to 80L) and high-density cell banking approaches
Conference Dates
February 1 – 5, 2026
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Omokhowa Agbojo, Ethan Feild, Sunghoon Jung, Breanna S. Borys, and Govanni Estrada, "Development of scalable, versatile, and cost-effective processes for iPSC-derived cell therapy manufacturing via linear scale-up (up to 80L) and high-density cell banking approaches" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/4